Acquisition by John Childs of 16592 shares of Biohaven Pharmaceutical at 38.8 subject to Rule 16b-3
| HMECX Fund | USD 18.91 0.01 0.05% |
Slightly above 56% of Highland Merger's investor base is looking to short. The analysis of overall sentiment of trading Highland Merger Arbitrage mutual fund suggests that many investors are alarmed at this time. Highland Merger's investing sentiment can be driven by a variety of factors including economic data, Highland Merger's earnings reports, geopolitical events, and overall market trends.
Highland |
Filed transaction by Biohaven Pharmaceutical Holding Director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Highland Merger Fundamental Analysis
We analyze Highland Merger's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Highland Merger using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Highland Merger based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Highland Merger is currently under evaluation in total asset among similar funds. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Highland Merger Arbitrage Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Highland Merger mutual fund to make a market-neutral strategy. Peer analysis of Highland Merger could also be used in its relative valuation, which is a method of valuing Highland Merger by comparing valuation metrics with similar companies.
Peers
Highland Merger Related Equities
| GMOZX | Gmo High | 0.22 | ||||
| MFHVX | Mesirow Financial | 0.12 | ||||
| MRHYX | Msift High | 0.12 | ||||
| HYSZX | Prudential Short | 0.12 | ||||
| FIHLX | Federated Institutional | 0.11 |
Other Information on Investing in Highland Mutual Fund
Highland Merger financial ratios help investors to determine whether Highland Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Highland with respect to the benefits of owning Highland Merger security.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |